Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Raine

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
United European Gastroenterology Journal|November 1, 2014
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?Tim Raine
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Insights from immunology: new targets for new drugs?Tim Raine
Gastroenterology|January 7, 2022
Breaking Through the Therapeutic Ceiling: What Will It Take?Tim Raine, Silvio Danese
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 16, 2005
MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs?Tim Raine, Rachel Allen
Therapeutic Advances in Musculoskeletal Disease|July 23, 2020
IBD considerations in spondyloarthritisCaroline Di Jiang, Tim Raine
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 19, 2022
Methotrexate in inflammatory bowel disease: A primer for gastroenterologistsTurki AlAmeel, Eman Al Sulais, Tim Raine
Nature Reviews. Gastroenterology & Hepatology|November 28, 2018
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targetingAlexander R Moschen, Herbert Tilg, Tim Raine
Journal of the National Cancer Institute|October 11, 2007
Atopy and risk of brain tumors: a meta-analysisEleni Linos, Tim Raine, Alvaro Alonso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetesTim Raine, Paola Zaccone, Pietro Mastroeni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cellsSven Brode, Tim Raine, Paola Zaccone, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
United European Gastroenterology Journal|November 1, 2014
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?Tim Raine
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Insights from immunology: new targets for new drugs?Tim Raine
Gastroenterology|January 7, 2022
Breaking Through the Therapeutic Ceiling: What Will It Take?Tim Raine, Silvio Danese
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 16, 2005
MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs?Tim Raine, Rachel Allen
Therapeutic Advances in Musculoskeletal Disease|July 23, 2020
IBD considerations in spondyloarthritisCaroline Di Jiang, Tim Raine
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 19, 2022
Methotrexate in inflammatory bowel disease: A primer for gastroenterologistsTurki AlAmeel, Eman Al Sulais, Tim Raine
Nature Reviews. Gastroenterology & Hepatology|November 28, 2018
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targetingAlexander R Moschen, Herbert Tilg, Tim Raine
Journal of the National Cancer Institute|October 11, 2007
Atopy and risk of brain tumors: a meta-analysisEleni Linos, Tim Raine, Alvaro Alonso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetesTim Raine, Paola Zaccone, Pietro Mastroeni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cellsSven Brode, Tim Raine, Paola Zaccone, et al.
Pageof 11